On day 1, GLP-1 was infused to stimulate endogenous insulin release and suppress endogenous glucagon. On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of ...
It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...
Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of ...
Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket ...
It is now widely recognised that host–microbiome interactions play a major role in the control of energy metabolism and ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
News Medical on MSN3d
Adrenomedullin hormone as key driver of insulin resistance in obesity-linked type 2 diabetesResearchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback